Phase 1 β Early testing in a small group of people (usually 20β80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(66 sites)
United States
USOR HonorHealth, Phoenix, Arizona USOR Arizona Oncology Associates, Tucson, Arizona University of California Los Angeles Medical Center, Los Angeles, California University of California, San Diego; Moores Cancer Center, San Diego, California USOR Sansum Clinic, Santa Barbara, California